Fineline Cube

Follow:
14398 Articles
AbbVie's Vyalev Wins FDA Approval as First Subcutaneous Levodopa Therapy for Advanced Parkinson's
CompanyDrug

AbbVie’s Vyalev Wins FDA Approval as First Subcutaneous Levodopa Therapy for Advanced Parkinson’s

Chengdu Drafts Comprehensive Policy to Stimulate Biomedical Industry Growth
Policy / Regulatory

Chengdu Drafts Comprehensive Policy to Stimulate Biomedical Industry Growth

Chongqing Zhifei Biological's EC Injection Receives Market Approval in Indonesia
CompanyDrug

Chongqing Zhifei Biological’s EC Injection Receives Market Approval in Indonesia

Tencent Invests USD 30 Million in Early Cancer Detection Firm Insighta, Backed by Prenetics
CompanyDeals

Tencent Invests USD 30 Million in Early Cancer Detection Firm Insighta, Backed by Prenetics

LaNova Medicines Secures RMB 300 Million in Series C1 Financing to Advance Cancer Therapy Pipeline
CompanyDeals

LaNova Medicines Secures RMB 300 Million in Series C1 Financing to Advance Cancer Therapy Pipeline

Abbott Laboratories Posts 9.4% Q3 Sales Growth, Driven by Medical Devices and Pharmaceuticals
Company

Abbott Laboratories Posts 9.4% Q3 Sales Growth, Driven by Medical Devices and Pharmaceuticals

Chengdu Baiyu Pharmaceutical Strikes Licensing Deal with Novartis for Unannounced Anti-Tumor Asset
CompanyDeals

Chengdu Baiyu Pharmaceutical Strikes Licensing Deal with Novartis for Unannounced Anti-Tumor Asset

Cryofocus Biotechnology Partners with Guangzhou Medical University Hospital for Cryoballoon Ablation R&D
CompanyDeals

Cryofocus Medtech Partners with Guangzhou Medical University Hospital for Cryoballoon Ablation R&D

Kintor Pharmaceutical Initiates Phase II/III Trial for KX-826 Tincture 1.0% in Treating Male Androgenetic Alopecia
CompanyDrug

Kintor Pharmaceutical Initiates Phase II/III Trial for KX-826 Tincture 1.0% in Treating Male Androgenetic Alopecia

Novocure’s Optune Lua Wins FDA Approval for mNSCLC Treatment in Combination with Immunotherapies
CompanyMedical Device

Novocure’s Optune Lua Wins FDA Approval for mNSCLC Treatment in Combination with Immunotherapies

Servier and HUST Forge Partnership to Cultivate Innovative Therapies through SHINEDocs Program
CompanyDeals

Servier and HUST Forge Partnership to Cultivate Innovative Therapies through SHINEDocs Program

Innovent Biologics' Picankibart Achieves Positive Results in Phase II UC Study
CompanyDrug

Innovent Biologics’ Picankibart Achieves Positive Results in Phase II UC Study